Revance

Revance

Biotechnology company for aesthetic solutions

About Revance

Simplify's Rating
Why Revance is rated
C+
Rated C on Competitive Edge
Rated A on Growth Potential
Rated D+ on Differentiation

Industries

Fintech

Biotechnology

Healthcare

Company Size

501-1,000

Company Stage

IPO

Headquarters

Nashville, Tennessee

Founded

1999

Overview

Revance Therapeutics focuses on biotechnology solutions in the aesthetics market, offering products that enhance physical appearance and improve patient outcomes. Their main products include neuromodulators, like botulinum toxin type A, which reduce wrinkles and treat muscle movement disorders, and dermal fillers that restore volume and smooth facial lines. Revance also explores therapeutic uses for its products in treating muscle movement and pain disorders. A unique aspect of Revance is its expansion into the fintech sector with the acquisition of HintMD, which streamlines payment processes for aesthetic practices. This integration allows Revance to provide a comprehensive suite of services to support aesthetic practitioners. The company aims to lead the premium aesthetics market by focusing on differentiated products and improved patient experiences.

Simplify Jobs

Simplify's Take

What believers are saying

  • The botulinum toxin market is projected to reach $9.1 billion by 2027.
  • Demand for dermal fillers is expected to reach $6.28 billion by 2028.
  • Increased consumer interest in minimally invasive procedures is growing by 8% annually.

What critics are saying

  • Increased competition in the neuromodulator market may impact Revance's market share.
  • Potential regulatory challenges in fintech could affect HintMD's integration.
  • DIY aesthetic treatments at home could reduce demand for professional services.

What makes Revance unique

  • Revance integrates fintech with HintMD to streamline aesthetic practice operations.
  • The company offers innovative neuromodulators and dermal fillers for minimally invasive procedures.
  • Revance's Blue Lizard Sunscreen is the #1 selling mineral sunscreen in the U.S.

Help us improve and share your feedback! Did you find this helpful?

Funding

Total Funding

$2485M

Above

Industry Average

Funded Over

9 Rounds

Acquisition funding comparison data is currently unavailable. We're working to provide this information soon!
Acquisition Funding Comparison
Coming Soon

Benefits

Health Insurance

Unlimited Paid Time Off

401(k) Company Match

Professional Development Budget

Stock Price

Growth & Insights and Company News

Headcount

6 month growth

↓ -2%

1 year growth

↓ -1%

2 year growth

↑ 0%
Teknovation
May 27th, 2025
Revance Announces Leadership Transition

Revance, a fast-growing global leader in aesthetics and skincare, has announced a leadership transition to support the companys next chapter of growth and innovation, as it builds toward becoming the... The post Revance announces leadership transition appeared first on Teknovation.biz.

PR Newswire
May 27th, 2025
Revance Announces Blue Lizard® Australian Sunscreen Times Square Takeover To Celebrate National Sunscreen Day

NASHVILLE, Tenn., May 27, 2025 /PRNewswire/ -- Revance is proud to announce that Blue Lizard® Australian Sunscreen, the #1 best-selling mineral SPF brand in the U.S.*, is celebrating National Sunscreen Day on May 27th with a dynamic digital billboard in New York City's Times Square, capping off Skin Cancer Awareness Month and heading into sun season with a bold message: Be Fearless in the Sun

Global Cosmetics News
May 23rd, 2025
Revance Names New CEO to Drive Next Phase in Aesthetic Innovation

Revance Therapeutics has announced a leadership succession plan, with founder and CEO Jeff Bedard transitioning to the role of Executive Chairman and Nadeem Moiz, the current President and CFO, appointed as the incoming Chief Executive Officer.

Barchart
May 21st, 2025
Revance Announces Blue Lizard Australian Sunscreen(R) Partnership with The Bentway for Their Summer 2025 Sun/Shade Program

NASHVILLE, Tenn., May 21, 2025 /CNW/ - Revance is proud to announce that Blue Lizard Australian Sunscreen(R) is partnering with The Bentway's Summer 2025 Sun/Shade program, a dynamic celebration of arts, culture, and community hosted in one of Toronto's most iconic public spaces: beneath the Gardiner Expressway.

PR Newswire
May 1st, 2025
Revance Announces Blue Lizard® Australian Sunscreen Named The #1 Selling Mineral Sunscreen Brand

NASHVILLE, Tenn., May 1, 2025 /PRNewswire/ -- Revance is thrilled to announce that Blue Lizard® Australian Sunscreen, a leader in mineral sun protection, is now the number one Selling Mineral Sunscreen Brand*. This exciting milestone reflects the growing consumer demand for high-performing, dermatologist-recommended sun protection that's both effective and gentle on sensitive skin

Recently Posted Jobs

Sign up to get curated job recommendations

Revance is Hiring for 7 Jobs on Simplify!

Find jobs on Simplify and start your career today

đź’ˇ
Don't see your dream role? Check out thousands of other roles on Simplify. Browse all jobs →